Stefania Farcomeni
Overview
Explore the profile of Stefania Farcomeni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scarpa F, Sernicola L, Farcomeni S, Ciccozzi A, Sanna D, Casu M, et al.
Pathogens
. 2024 Apr;
13(4).
PMID: 38668289
The influenza A(H1N1) pdm09 virus, which emerged in 2009, has been circulating seasonally since then. In this study, we conducted a comprehensive genome-based investigation to gain a detailed understanding of...
2.
Branda F, Giovanetti M, Sernicola L, Farcomeni S, Ciccozzi M, Borsetti A
Pathogens
. 2024 Feb;
13(2).
PMID: 38392840
The growing emergence of non-nucleoside reverse transcriptase inhibitor (NNRTI) HIV drug resistance in sub-Saharan Africa (SSA) led to the World Health Organization (WHO) recommending, in 2018, a transition to dolutegravir...
3.
Cafaro A, Schietroma I, Sernicola L, Belli R, Campagna M, Mancini F, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338977
Each time the virus starts a new round of expression/replication, even under effective antiretroviral therapy (ART), the transactivator of viral transcription Tat is one of the first HIV-1 protein to...
4.
Moretti S, Schietroma I, Sberna G, Maggiorella M, Sernicola L, Farcomeni S, et al.
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569570
HIV-1 replication in the gastrointestinal (GI) tract causes severe CD4+ T-cell depletion and disruption of the protective epithelial barrier in the intestinal mucosa, causing microbial translocation, the main driver of...
5.
Giovanetti M, Farcomeni S, Sernicola L, Virtuoso S, Fontanelli Sulekova L, Maggiorella M, et al.
J Med Virol
. 2022 Mar;
94(7):3320-3327.
PMID: 35277871
HIV-1 genetic diversity and drug resistance mutations remain public health challenges especially in regions where treatment is limited. The aim of this study was to characterize the HIV-1 integrase (IN)...
6.
Farcomeni S, Moretti S, Fimiani C, Fontanelli Sulekova L, Vescio F, Sernicola L, et al.
Pathogens
. 2021 Nov;
10(11).
PMID: 34832642
Background: Direct-acting antivirals (DAAs) treatment, although highly efficacious for the treatment of hepatitis C virus (HCV) infection, may not completely reconstitute the HCV-mediated dysregulated immune system, especially in patients co-infected...
7.
Moretti S, Virtuoso S, Sernicola L, Farcomeni S, Maggiorella M, Borsetti A
Pathogens
. 2021 Aug;
10(8).
PMID: 34451482
Non-human primates (NHPs) are the most relevant model of Acquired Immunodeficiency Syndrome (AIDS) and neuroAIDS, being of great importance in explaining the pathogenesis of HIV-induced nervous system damage. Simian Immunodeficiency...
8.
Lo Presti A, Farcomeni S, Fontanelli Sulekova L, Grieco S, Sernicola L, Baesso M, et al.
AIDS Res Hum Retroviruses
. 2019 Jul;
35(10):968-971.
PMID: 31280584
There is scarce data on circulation of genetic subtypes of HIV-1 in South Sudan due to decades of civil war. In this study, phylogenetic analysis of 10 strains collected from...
9.
Acchioni C, Remoli A, Marsili G, Acchioni M, Nardolillo I, Orsatti R, et al.
J Virol
. 2019 Jun;
93(18).
PMID: 31243131
Current combination antiretroviral therapies (cART) are unable to eradicate HIV-1 from infected individuals because of the establishment of proviral latency in long-lived cellular reservoirs. The shock-and-kill approach aims to reactivate...
10.
Capone A, Lo Presti A, Sernicola L, Farcomeni S, Ferrantelli F, Maggiorella M, et al.
J Gen Virol
. 2018 Oct;
99(12):1717-1728.
PMID: 30311877
Intra-host evolution of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) has been shown by viral RNA analysis in subjects who naturally suppress plasma viremia to low levels, known...